These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 16250633)

  • 21. Nonpolar and short side chain groups at C-11beta of estradiol result in antiestrogens.
    Zhang JX; Labaree DC; Hochberg RB
    J Med Chem; 2005 Mar; 48(5):1428-47. PubMed ID: 15743187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estrogen receptor ligands. Part 10: Chromanes: old scaffolds for new SERAMs.
    Tan Q; Blizzard TA; Morgan JD; Birzin ET; Chan W; Yang YT; Pai LY; Hayes EC; DaSilva CA; Warrier S; Yudkovitz J; Wilkinson HA; Sharma N; Fitzgerald PM; Li S; Colwell L; Fisher JE; Adamski S; Reszka AA; Kimmel D; DiNinno F; Rohrer SP; Freedman LP; Schaeffer JM; Hammond ML
    Bioorg Med Chem Lett; 2005 Mar; 15(6):1675-81. PubMed ID: 15745820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and biochemical characterization of a series of 17α-perfluoroalkylated estradiols as selective ligands for estrogen receptor α.
    Eignerová B; Sedlák D; Dracínský M; Bartunek P; Kotora M
    J Med Chem; 2010 Oct; 53(19):6947-53. PubMed ID: 20812681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure-activity relationships of selective estrogen receptor modulators: modifications to the 2-arylbenzothiophene core of raloxifene.
    Grese TA; Cho S; Finley DR; Godfrey AG; Jones CD; Lugar CW; Martin MJ; Matsumoto K; Pennington LD; Winter MA; Adrian MD; Cole HW; Magee DE; Phillips DL; Rowley ER; Short LL; Glasebrook AL; Bryant HU
    J Med Chem; 1997 Jan; 40(2):146-67. PubMed ID: 9003514
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis of 3-alkyl naphthalenes as novel estrogen receptor ligands.
    Fang J; Akwabi-Ameyaw A; Britton JE; Katamreddy SR; Navas F; Miller AB; Williams SP; Gray DW; Orband-Miller LA; Shearin J; Heyer D
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5075-7. PubMed ID: 18722117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The combination of a novel selective estrogen receptor modulator with an estrogen protects the mammary gland and uterus in a rodent model: the future of postmenopausal women's health?
    Labrie F; El-Alfy M; Berger L; Labrie C; Martel C; Bélanger A; Candas B; Pelletier G
    Endocrinology; 2003 Nov; 144(11):4700-6. PubMed ID: 12960051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of oestrogen receptors alpha and beta during the period of uterine receptivity in rat: effect of ormeloxifene, a selective oestrogen receptor modulator.
    Awasthi S; Blesson CS; Dwivedi A
    Acta Physiol (Oxf); 2007 Jan; 189(1):47-56. PubMed ID: 17280556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design and synthesis of aryl diphenolic azoles as potent and selective estrogen receptor-beta ligands.
    Malamas MS; Manas ES; McDevitt RE; Gunawan I; Xu ZB; Collini MD; Miller CP; Dinh T; Henderson RA; Keith JC; Harris HA
    J Med Chem; 2004 Oct; 47(21):5021-40. PubMed ID: 15456246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of ligand selectivity using reporter cell lines stably expressing estrogen receptor alpha or beta.
    Escande A; Pillon A; Servant N; Cravedi JP; Larrea F; Muhn P; Nicolas JC; Cavaillès V; Balaguer P
    Biochem Pharmacol; 2006 May; 71(10):1459-69. PubMed ID: 16554039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification and structure-activity relationships of chromene-derived selective estrogen receptor modulators for treatment of postmenopausal symptoms.
    Jain N; Xu J; Kanojia RM; Du F; Jian-Zhong G; Pacia E; Lai MT; Musto A; Allan G; Reuman M; Li X; Hahn D; Cousineau M; Peng S; Ritchie D; Russell R; Lundeen S; Sui Z
    J Med Chem; 2009 Dec; 52(23):7544-69. PubMed ID: 19366247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The selective estrogen receptor modulator trioxifene (LY133314) inhibits metastasis and extends survival in the PAIII rat prostatic carcinoma model.
    Neubauer BL; McNulty AM; Chedid M; Chen K; Goode RL; Johnson MA; Jones CD; Krishnan V; Lynch R; Osborne HE; Graff JR
    Cancer Res; 2003 Sep; 63(18):6056-62. PubMed ID: 14522935
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estrogen receptor ligands. Part 4: The SAR of the syn-dihydrobenzoxathiin SERAMs.
    Kim S; Wu J; Chen HY; Birzin ET; Chan W; Yang YT; Colwell L; Li S; Dahllund J; DiNinno F; Rohrer SP; Schaeffer JM; Hammond ML
    Bioorg Med Chem Lett; 2004 Jun; 14(11):2741-5. PubMed ID: 15125925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Benzothiophenes containing a piperazine side chain as selective ligands for the estrogen receptor alpha and their bioactivities in vivo.
    Yang C; Xu G; Li J; Wu X; Liu B; Yan X; Wang M; Xie Y
    Bioorg Med Chem Lett; 2005 Mar; 15(5):1505-7. PubMed ID: 15713417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tissue- and hormone-dependent progesterone receptor distribution in the rat uterus.
    Sahlin L; Masironi B; Akerberg S; Eriksson H
    Reprod Biol Endocrinol; 2006 Sep; 4():47. PubMed ID: 16965620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of 8-prenylnaringenin on the hypothalamo-pituitary-uterine axis in rats after 3-month treatment.
    Christoffel J; Rimoldi G; Wuttke W
    J Endocrinol; 2006 Mar; 188(3):397-405. PubMed ID: 16522720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dissecting physiological roles of estrogen receptor alpha and beta with potent selective ligands from structure-based design.
    Hillisch A; Peters O; Kosemund D; Müller G; Walter A; Schneider B; Reddersen G; Elger W; Fritzemeier KH
    Mol Endocrinol; 2004 Jul; 18(7):1599-609. PubMed ID: 15105439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estrogen receptors: therapies targeted to receptor subtypes.
    Nilsson S; Gustafsson JÅ
    Clin Pharmacol Ther; 2011 Jan; 89(1):44-55. PubMed ID: 21124311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel chromene-derived selective estrogen receptor modulators useful for alleviating hot flushes and vaginal dryness.
    Jain N; Kanojia RM; Xu J; Jian-Zhong G; Pacia E; Lai MT; Du F; Musto A; Allan G; Hahn D; Lundeen S; Sui Z
    J Med Chem; 2006 Jun; 49(11):3056-9. PubMed ID: 16722623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subtle side-chain modifications of the hop phytoestrogen 8-prenylnaringenin result in distinct agonist/antagonist activity profiles for estrogen receptors alpha and beta.
    Roelens F; Heldring N; Dhooge W; Bengtsson M; Comhaire F; Gustafsson JA; Treuter E; De Keukeleire D
    J Med Chem; 2006 Dec; 49(25):7357-65. PubMed ID: 17149865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unique SERM-like properties of the novel fluorescent tamoxifen derivative FLTX1.
    Marrero-Alonso J; Morales A; García Marrero B; Boto A; Marín R; Cury D; Gómez T; Fernández-Pérez L; Lahoz F; Díaz M
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):898-910. PubMed ID: 23727370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.